Bone changes with candidate PrEP regimens containing tenofovir disoproxil fumarate and/or maraviroc and/or emtricitabine in US men and women: HPTN 069/ACTG A5305Todd T. Brown, Timothy Wilkin, Kenneth H. Mayer et al.|Journal of Antimicrobial Chemotherapy|2021Cited by 5